AVANTI
DEAD

Serial Number

79417423

Owner

Croda International Plc

Filing Date

Jul 18, 2024

Add to watchlist:

No watchlists yet
View on USPTO

AVANTI Trademark

Serial Number: 79417423

AVANTI is a trademark filed by Croda International Plc on July 18, 2024. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

Croda International Plc

Cowick Hall, Snaith

Entity Type: 84

Trademark Details

Filing Date

July 18, 2024

Registration Date

Not Registered

Goods & Services

Lipids, synthetic lipids, polymer modified lipids, lipids with modified head groups, lipids with modified acyl chains, bioactive lipids, fluorescent lipids, isotope labelled lipids, oxidized lipids, lipid extracts from natural sources, biological compounds conjugated with modified gold particles, fatty acids, glycerolipids, glycerophospholipids, sphingolipids, glycosphingolipids, saccharolipids, sterol lipids, prenol lipids, lipid preparations suitable for protein crystallization, lipid preparations suitable for protein solubilization, detergents, amphiphilic detergents, and antibodies, active agents, additives, and excipients in pharmaceutical preparations; adjuvants, polymers and excipients, including surfactants, dispersants, diluents, disintegrants, emulsifiers, binders, stabilisers and fillers, for pharmaceutical or medical use; immunostimulatory compounds for pharmaceutical or medical use; isotopes for medical use; transfection reagents for pharmaceutical or medical use; amino acids, peptides, nucleosides, nucleotides and sugars, and lipid conjugated versions of the aforesaid, for pharmaceutical or medical use; drug delivery auxiliary agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals.

Analytical laboratory services; scientific research for medical purposes; analytical laboratory services in the field of lipids, nutraceuticals, food products, pharmaceutical products, drug development and commercialization; research and development and consultation related thereto in the field of pharmaceuticals and chemicals; research services for others; research services for others in the field of lipids, nutraceuticals, food products, pharmaceutical products, drug development and commercialization; lipidomics services, namely analytical services relating to lipid metabolism in biological systems; cGMP testing services; formulation chemistry services in the field of pharmaceuticals, lipids, and chemicals; providing information relating to lipids and related compounds for scientific and medical research purposes.

Chemical compounds for scientific or research use; lipid compounds for scientific or research use; adjuvants, polymers and excipients, including surfactants, dispersants, diluents, disintegrants, emulsifiers, binders, stabilisers and fillers, for scientific or research use; transfection reagents for scientific or research use; chemical reagents for the delivery of lipids for scientific or research use; standard solutions for use with analytical techniques, namely, mass spectrometry; lipids, synthetic lipids, polymer modified lipids, lipids with modified head groups, lipids with modified acyl chains, bioactive lipids, fluorescent lipids, isotope labelled lipids, oxidized lipids, lipid extracts from natural sources, biological compounds conjugated with modified gold particles; fatty acids, glycerolipids, glycerophospholipids, sphingolipids, glycosphingolipids, saccharolipids, sterol lipids, prenol lipids, lipid preparations suitable for protein crystallization, lipid preparations suitable for protein solubilization, detergents, amphiphilic detergents, and antibodies; amino acids, peptides, nucleosides, nucleotides and sugars, and lipid conjugated versions of the aforesaid, for scientific or research use; diagnostic and analytical reagents for scientific or research use; formulations comprising lipids for scientific or research use; enzymes for scientific or research use; fluorophores and fluorescent probes for scientific or research use; chemical auxiliary agents as raw materials for manufacturing pharmaceutical preparations, nutrient preparations, and food supplements.

Manufacturing services for others in the field of active agents, additives, or excipients for pharmaceutical preparations; manufacturing services for others in the field of lipids; cGMP manufacture of active agents, additives, or excipients, for others; cGMP manufacture of lipids, for others; manufacturing services for others in the field of active agents, additives, or excipients in pharmaceutical preparations; manufacturing services for others in the field of lipids.

Apparatus and instruments for scientific research in laboratories.

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Apr 9, 2026 NREP
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Oct 21, 2025 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Oct 21, 2025 ABN2
REFUSAL PROCESSED BY IB
Apr 26, 2025 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Apr 9, 2025 RFCS
REFUSAL PROCESSED BY MPU
Apr 8, 2025 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 4, 2025 RFCR
NON-FINAL ACTION WRITTEN
Mar 3, 2025 CNRT
ASSIGNED TO EXAMINER
Feb 24, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
Feb 23, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 23, 2025 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Feb 20, 2025 REPR